Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030 Article Swipe
David Sarley
,
Angela Hwang
,
B. Fenton Hall
,
Andrew Ford
,
Birgitte Giersing
,
David C. Kaslow
,
Brian Wahl
,
Martin Friede
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1016/j.vaccine.2022.11.041
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1016/j.vaccine.2022.11.041
Research and innovation have been fundamental to many of the successes in immunization thus far, and will play important roles in the future success of Immunization Agenda 2030 (IA2030). Strategic Priority 7 (SP7) of IA2030, which addresses research and innovation, is explicitly informed by country needs and priorities, and aims to strengthen the innovation ecosystem through capacity building and collaboration at country, regional, and global levels. SP7 identifies four key focus areas: (1) "needs-based innovation", (2) "new and improved products, services, and practices", (3) "evidence for implementation", and (4) "local capacity". Strategic interventions in these key focus areas apply the lessons of the Global Vaccine Action Plan and the "Decade of Vaccines" to emphasize local innovation, promote the use of research by countries to improve program performance and impact, and encourage capacity building for the development and implementation of innovations. The proposed approach will maintain a focus on the development of new vaccines and the improvement of existing vaccines, and increase attention to innovation in service delivery. Monitoring and evaluation will foster evidence-based priority setting at the country level and help to ground the global research and development (R&D) agenda in the needs of communities. Together, these approaches are intended to harness the power of research and innovation more effectively, to meet the challenges of the future and achieve the ambitious goals of IA2030.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.vaccine.2022.11.041
- OA Status
- hybrid
- Cited By
- 4
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4311929399
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4311929399Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.vaccine.2022.11.041Digital Object Identifier
- Title
-
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-12-16Full publication date if available
- Authors
-
David Sarley, Angela Hwang, B. Fenton Hall, Andrew Ford, Birgitte Giersing, David C. Kaslow, Brian Wahl, Martin FriedeList of authors in order
- Landing page
-
https://doi.org/10.1016/j.vaccine.2022.11.041Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.vaccine.2022.11.041Direct OA link when available
- Concepts
-
Immunization, Business, Medicine, Political science, Immunology, AntibodyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 2, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4311929399 |
|---|---|
| doi | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| ids.doi | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36529593 |
| ids.openalex | https://openalex.org/W4311929399 |
| fwci | 0.83485577 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D014943 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Global Health |
| mesh[2].qualifier_ui | Q000458 |
| mesh[2].descriptor_ui | D017589 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | organization & administration |
| mesh[2].descriptor_name | Immunization Programs |
| mesh[3].qualifier_ui | Q000639 |
| mesh[3].descriptor_ui | D017589 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | trends |
| mesh[3].descriptor_name | Immunization Programs |
| mesh[4].qualifier_ui | Q000639 |
| mesh[4].descriptor_ui | D007114 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | trends |
| mesh[4].descriptor_name | Immunization |
| mesh[5].qualifier_ui | Q000379 |
| mesh[5].descriptor_ui | D007114 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | methods |
| mesh[5].descriptor_name | Immunization |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D014612 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Vaccines |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D057191 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Capacity Building |
| mesh[8].qualifier_ui | Q000639 |
| mesh[8].descriptor_ui | D012106 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | trends |
| mesh[8].descriptor_name | Research |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006297 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Health Services Accessibility |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D014943 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Global Health |
| mesh[12].qualifier_ui | Q000458 |
| mesh[12].descriptor_ui | D017589 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | organization & administration |
| mesh[12].descriptor_name | Immunization Programs |
| mesh[13].qualifier_ui | Q000639 |
| mesh[13].descriptor_ui | D017589 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | trends |
| mesh[13].descriptor_name | Immunization Programs |
| mesh[14].qualifier_ui | Q000639 |
| mesh[14].descriptor_ui | D007114 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | trends |
| mesh[14].descriptor_name | Immunization |
| mesh[15].qualifier_ui | Q000379 |
| mesh[15].descriptor_ui | D007114 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | methods |
| mesh[15].descriptor_name | Immunization |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D014612 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Vaccines |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D057191 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Capacity Building |
| mesh[18].qualifier_ui | Q000639 |
| mesh[18].descriptor_ui | D012106 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | trends |
| mesh[18].descriptor_name | Research |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Health Services Accessibility |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D014943 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Global Health |
| mesh[22].qualifier_ui | Q000458 |
| mesh[22].descriptor_ui | D017589 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | organization & administration |
| mesh[22].descriptor_name | Immunization Programs |
| mesh[23].qualifier_ui | Q000639 |
| mesh[23].descriptor_ui | D017589 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | trends |
| mesh[23].descriptor_name | Immunization Programs |
| mesh[24].qualifier_ui | Q000639 |
| mesh[24].descriptor_ui | D007114 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | trends |
| mesh[24].descriptor_name | Immunization |
| mesh[25].qualifier_ui | Q000379 |
| mesh[25].descriptor_ui | D007114 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | methods |
| mesh[25].descriptor_name | Immunization |
| mesh[26].qualifier_ui | Q000008 |
| mesh[26].descriptor_ui | D014612 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | administration & dosage |
| mesh[26].descriptor_name | Vaccines |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D057191 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Capacity Building |
| mesh[28].qualifier_ui | Q000639 |
| mesh[28].descriptor_ui | D012106 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | trends |
| mesh[28].descriptor_name | Research |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D006297 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Health Services Accessibility |
| type | article |
| title | Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030 |
| biblio.issue | |
| biblio.volume | 42 |
| biblio.last_page | S90 |
| biblio.first_page | S82 |
| grants[0].funder | https://openalex.org/F4320306137 |
| grants[0].award_id | INV-003658 |
| grants[0].funder_display_name | Bill and Melinda Gates Foundation |
| topics[0].id | https://openalex.org/T10833 |
| topics[0].field.id | https://openalex.org/fields/33 |
| topics[0].field.display_name | Social Sciences |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3306 |
| topics[0].subfield.display_name | Health |
| topics[0].display_name | Vaccine Coverage and Hesitancy |
| topics[1].id | https://openalex.org/T10167 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Influenza Virus Research Studies |
| topics[2].id | https://openalex.org/T10118 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9968000054359436 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | SARS-CoV-2 and COVID-19 Research |
| funders[0].id | https://openalex.org/F4320306137 |
| funders[0].ror | https://ror.org/0456r8d26 |
| funders[0].display_name | Bill and Melinda Gates Foundation |
| is_xpac | False |
| apc_list.value | 3500 |
| apc_list.currency | USD |
| apc_list.value_usd | 3500 |
| apc_paid.value | 3500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3500 |
| concepts[0].id | https://openalex.org/C2780801004 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8586456775665283 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1415366 |
| concepts[0].display_name | Immunization |
| concepts[1].id | https://openalex.org/C144133560 |
| concepts[1].level | 0 |
| concepts[1].score | 0.4158828854560852 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[1].display_name | Business |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.40614941716194153 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C17744445 |
| concepts[3].level | 0 |
| concepts[3].score | 0.39241823554039 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[3].display_name | Political science |
| concepts[4].id | https://openalex.org/C203014093 |
| concepts[4].level | 1 |
| concepts[4].score | 0.23382404446601868 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[4].display_name | Immunology |
| concepts[5].id | https://openalex.org/C159654299 |
| concepts[5].level | 2 |
| concepts[5].score | 0.09609180688858032 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[5].display_name | Antibody |
| keywords[0].id | https://openalex.org/keywords/immunization |
| keywords[0].score | 0.8586456775665283 |
| keywords[0].display_name | Immunization |
| keywords[1].id | https://openalex.org/keywords/business |
| keywords[1].score | 0.4158828854560852 |
| keywords[1].display_name | Business |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.40614941716194153 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/political-science |
| keywords[3].score | 0.39241823554039 |
| keywords[3].display_name | Political science |
| keywords[4].id | https://openalex.org/keywords/immunology |
| keywords[4].score | 0.23382404446601868 |
| keywords[4].display_name | Immunology |
| keywords[5].id | https://openalex.org/keywords/antibody |
| keywords[5].score | 0.09609180688858032 |
| keywords[5].display_name | Antibody |
| language | en |
| locations[0].id | doi:10.1016/j.vaccine.2022.11.041 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S27359860 |
| locations[0].source.issn | 0264-410X, 1873-2518 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0264-410X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Vaccine |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Vaccine |
| locations[0].landing_page_url | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| locations[1].id | pmid:36529593 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Vaccine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36529593 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5041916405 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | David Sarley |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1303444417 |
| authorships[0].affiliations[0].raw_affiliation_string | Bill & Melinda Gates Foundation, Seattle, WA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1303444417 |
| authorships[0].institutions[0].ror | https://ror.org/0456r8d26 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I1303444417 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Gates Foundation |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | David Sarley |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Bill & Melinda Gates Foundation, Seattle, WA, USA |
| authorships[1].author.id | https://openalex.org/A5059416776 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7937-3333 |
| authorships[1].author.display_name | Angela Hwang |
| authorships[1].affiliations[0].raw_affiliation_string | Consultant, Albany, CA, USA |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Angela Hwang |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Consultant, Albany, CA, USA |
| authorships[2].author.id | https://openalex.org/A5104098370 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | B. Fenton Hall |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[2].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[2].institutions[1].id | https://openalex.org/I1299303238 |
| authorships[2].institutions[1].ror | https://ror.org/01cwqze88 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | National Institutes of Health |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | B. Fenton Hall |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA |
| authorships[3].author.id | https://openalex.org/A5050274261 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Andrew Ford |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[3].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[3].institutions[1].id | https://openalex.org/I1299303238 |
| authorships[3].institutions[1].ror | https://ror.org/01cwqze88 |
| authorships[3].institutions[1].type | government |
| authorships[3].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | National Institutes of Health |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Andrew Ford |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA |
| authorships[4].author.id | https://openalex.org/A5059954742 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2555-7756 |
| authorships[4].author.display_name | Birgitte Giersing |
| authorships[4].countries | CH |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[4].affiliations[0].raw_affiliation_string | World Health Organization, Geneva, Switzerland |
| authorships[4].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[4].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[4].institutions[0].country_code | CH |
| authorships[4].institutions[0].display_name | World Health Organization |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Birgitte Giersing |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | World Health Organization, Geneva, Switzerland |
| authorships[5].author.id | https://openalex.org/A5011187406 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3557-383X |
| authorships[5].author.display_name | David C. Kaslow |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1304598786 |
| authorships[5].affiliations[0].raw_affiliation_string | PATH, Seattle, WA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1304598786 |
| authorships[5].institutions[0].ror | https://ror.org/02ycvrx49 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I1304598786 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Program for Appropriate Technology in Health |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | David C. Kaslow |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | PATH, Seattle, WA, USA |
| authorships[6].author.id | https://openalex.org/A5055551851 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0037-7364 |
| authorships[6].author.display_name | Brian Wahl |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I145311948 |
| authorships[6].affiliations[1].raw_affiliation_string | International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA |
| authorships[6].institutions[0].id | https://openalex.org/I145311948 |
| authorships[6].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Johns Hopkins University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Brian Wahl |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA |
| authorships[7].author.id | https://openalex.org/A5083790715 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Martin Friede |
| authorships[7].countries | CH |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[7].affiliations[0].raw_affiliation_string | World Health Organization, Geneva, Switzerland |
| authorships[7].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[7].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[7].institutions[0].country_code | CH |
| authorships[7].institutions[0].display_name | World Health Organization |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Martin Friede |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | World Health Organization, Geneva, Switzerland |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10833 |
| primary_topic.field.id | https://openalex.org/fields/33 |
| primary_topic.field.display_name | Social Sciences |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3306 |
| primary_topic.subfield.display_name | Health |
| primary_topic.display_name | Vaccine Coverage and Hesitancy |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.vaccine.2022.11.041 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S27359860 |
| best_oa_location.source.issn | 0264-410X, 1873-2518 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0264-410X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Vaccine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Vaccine |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| primary_location.id | doi:10.1016/j.vaccine.2022.11.041 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S27359860 |
| primary_location.source.issn | 0264-410X, 1873-2518 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0264-410X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Vaccine |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Vaccine |
| primary_location.landing_page_url | https://doi.org/10.1016/j.vaccine.2022.11.041 |
| publication_date | 2022-12-16 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W3123481858, https://openalex.org/W2329892735, https://openalex.org/W2600932679, https://openalex.org/W2976083476, https://openalex.org/W3000717116, https://openalex.org/W2985393490, https://openalex.org/W3013660050, https://openalex.org/W3131672727, https://openalex.org/W2766777595, https://openalex.org/W3154600474, https://openalex.org/W4212791434, https://openalex.org/W4213102216, https://openalex.org/W4214813278, https://openalex.org/W3123403395, https://openalex.org/W3194550207, https://openalex.org/W6810078929, https://openalex.org/W3173577444, https://openalex.org/W4254848468, https://openalex.org/W3212649400, https://openalex.org/W3193448724, https://openalex.org/W6754488029, https://openalex.org/W4221017196, https://openalex.org/W2888967035 |
| referenced_works_count | 23 |
| abstract_inverted_index.7 | 31 |
| abstract_inverted_index.a | 145 |
| abstract_inverted_index.at | 60, 175 |
| abstract_inverted_index.by | 43, 121 |
| abstract_inverted_index.in | 11, 20, 93, 164, 190 |
| abstract_inverted_index.is | 40 |
| abstract_inverted_index.of | 8, 24, 33, 101, 110, 119, 138, 150, 156, 193, 204, 214, 222 |
| abstract_inverted_index.on | 147 |
| abstract_inverted_index.to | 6, 50, 112, 123, 162, 181, 200, 210 |
| abstract_inverted_index.(1) | 72 |
| abstract_inverted_index.(2) | 75 |
| abstract_inverted_index.(3) | 83 |
| abstract_inverted_index.(4) | 88 |
| abstract_inverted_index.SP7 | 66 |
| abstract_inverted_index.The | 140 |
| abstract_inverted_index.and | 1, 15, 38, 46, 48, 58, 63, 77, 81, 87, 107, 127, 129, 136, 153, 159, 168, 179, 186, 206, 217 |
| abstract_inverted_index.are | 198 |
| abstract_inverted_index.for | 85, 133 |
| abstract_inverted_index.key | 69, 95 |
| abstract_inverted_index.new | 151 |
| abstract_inverted_index.the | 9, 21, 52, 99, 102, 108, 117, 134, 148, 154, 176, 183, 191, 202, 212, 215, 219 |
| abstract_inverted_index.use | 118 |
| abstract_inverted_index."new | 76 |
| abstract_inverted_index.2030 | 27 |
| abstract_inverted_index.Plan | 106 |
| abstract_inverted_index.aims | 49 |
| abstract_inverted_index.been | 4 |
| abstract_inverted_index.far, | 14 |
| abstract_inverted_index.four | 68 |
| abstract_inverted_index.have | 3 |
| abstract_inverted_index.help | 180 |
| abstract_inverted_index.many | 7 |
| abstract_inverted_index.meet | 211 |
| abstract_inverted_index.more | 208 |
| abstract_inverted_index.play | 17 |
| abstract_inverted_index.thus | 13 |
| abstract_inverted_index.will | 16, 143, 170 |
| abstract_inverted_index.(R&D) | 188 |
| abstract_inverted_index.(SP7) | 32 |
| abstract_inverted_index.apply | 98 |
| abstract_inverted_index.areas | 97 |
| abstract_inverted_index.focus | 70, 96, 146 |
| abstract_inverted_index.goals | 221 |
| abstract_inverted_index.level | 178 |
| abstract_inverted_index.local | 114 |
| abstract_inverted_index.needs | 45, 192 |
| abstract_inverted_index.power | 203 |
| abstract_inverted_index.roles | 19 |
| abstract_inverted_index.these | 94, 196 |
| abstract_inverted_index.which | 35 |
| abstract_inverted_index."local | 89 |
| abstract_inverted_index.Action | 105 |
| abstract_inverted_index.Agenda | 26 |
| abstract_inverted_index.Global | 103 |
| abstract_inverted_index.agenda | 189 |
| abstract_inverted_index.areas: | 71 |
| abstract_inverted_index.foster | 171 |
| abstract_inverted_index.future | 22, 216 |
| abstract_inverted_index.global | 64, 184 |
| abstract_inverted_index.ground | 182 |
| abstract_inverted_index."Decade | 109 |
| abstract_inverted_index.IA2030, | 34 |
| abstract_inverted_index.IA2030. | 223 |
| abstract_inverted_index.Vaccine | 104 |
| abstract_inverted_index.achieve | 218 |
| abstract_inverted_index.country | 44, 177 |
| abstract_inverted_index.harness | 201 |
| abstract_inverted_index.impact, | 128 |
| abstract_inverted_index.improve | 124 |
| abstract_inverted_index.lessons | 100 |
| abstract_inverted_index.levels. | 65 |
| abstract_inverted_index.program | 125 |
| abstract_inverted_index.promote | 116 |
| abstract_inverted_index.service | 165 |
| abstract_inverted_index.setting | 174 |
| abstract_inverted_index.success | 23 |
| abstract_inverted_index.through | 55 |
| abstract_inverted_index.Priority | 30 |
| abstract_inverted_index.Research | 0 |
| abstract_inverted_index.approach | 142 |
| abstract_inverted_index.building | 57, 132 |
| abstract_inverted_index.capacity | 56, 131 |
| abstract_inverted_index.country, | 61 |
| abstract_inverted_index.existing | 157 |
| abstract_inverted_index.improved | 78 |
| abstract_inverted_index.increase | 160 |
| abstract_inverted_index.informed | 42 |
| abstract_inverted_index.intended | 199 |
| abstract_inverted_index.maintain | 144 |
| abstract_inverted_index.priority | 173 |
| abstract_inverted_index.proposed | 141 |
| abstract_inverted_index.research | 37, 120, 185, 205 |
| abstract_inverted_index.vaccines | 152 |
| abstract_inverted_index."evidence | 84 |
| abstract_inverted_index.(IA2030). | 28 |
| abstract_inverted_index.Strategic | 29, 91 |
| abstract_inverted_index.Together, | 195 |
| abstract_inverted_index.Vaccines" | 111 |
| abstract_inverted_index.addresses | 36 |
| abstract_inverted_index.ambitious | 220 |
| abstract_inverted_index.attention | 161 |
| abstract_inverted_index.countries | 122 |
| abstract_inverted_index.delivery. | 166 |
| abstract_inverted_index.ecosystem | 54 |
| abstract_inverted_index.emphasize | 113 |
| abstract_inverted_index.encourage | 130 |
| abstract_inverted_index.important | 18 |
| abstract_inverted_index.products, | 79 |
| abstract_inverted_index.regional, | 62 |
| abstract_inverted_index.services, | 80 |
| abstract_inverted_index.successes | 10 |
| abstract_inverted_index.vaccines, | 158 |
| abstract_inverted_index.Monitoring | 167 |
| abstract_inverted_index.approaches | 197 |
| abstract_inverted_index.capacity". | 90 |
| abstract_inverted_index.challenges | 213 |
| abstract_inverted_index.evaluation | 169 |
| abstract_inverted_index.explicitly | 41 |
| abstract_inverted_index.identifies | 67 |
| abstract_inverted_index.innovation | 2, 53, 163, 207 |
| abstract_inverted_index.strengthen | 51 |
| abstract_inverted_index.development | 135, 149, 187 |
| abstract_inverted_index.fundamental | 5 |
| abstract_inverted_index.improvement | 155 |
| abstract_inverted_index.innovation, | 39, 115 |
| abstract_inverted_index.performance | 126 |
| abstract_inverted_index.practices", | 82 |
| abstract_inverted_index.priorities, | 47 |
| abstract_inverted_index."needs-based | 73 |
| abstract_inverted_index.Immunization | 25 |
| abstract_inverted_index.communities. | 194 |
| abstract_inverted_index.effectively, | 209 |
| abstract_inverted_index.immunization | 12 |
| abstract_inverted_index.innovation", | 74 |
| abstract_inverted_index.innovations. | 139 |
| abstract_inverted_index.collaboration | 59 |
| abstract_inverted_index.interventions | 92 |
| abstract_inverted_index.evidence-based | 172 |
| abstract_inverted_index.implementation | 137 |
| abstract_inverted_index.implementation", | 86 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5059416776 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 8 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/9 |
| sustainable_development_goals[0].score | 0.6100000143051147 |
| sustainable_development_goals[0].display_name | Industry, innovation and infrastructure |
| citation_normalized_percentile.value | 0.70449829 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |